Roche Atezolizumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Halozyme Therapeutics Inc (HALO) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Halozyme Therapeutics Inc (NASDAQ: HALO)
Q1 2021 Earnings Call
Operator
Good day, and thank you for standing by. Welcome to the Halozyme First Quarter 2021 Financial Results Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Al Kildani, Vice President of Investor Relations and Corporate Communications. Thank you. Please go ahead.SPONSORED:
10 stocks we like better than Halozyme Therapeutics
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

Anita Dushyanth Berenberg , Joe Catanzaro , Roy Buchanan , Graig Suvannavejh , Jessica Fye , Joe Catanzaro Piper Sandler , Herceptin Hylecta , Helen Torley , Takeda Hyqvia , Al Kildani , Jason Butler , Roche Tecentriq , Piper Sandler , Bristol Myers Squibb , Elaine Sun , Roche Atezolizumab , Roche Phesgo , Anita Dushyanth , Graig Suvannavejh Goldman Sachs , Development Agreement , Motley Fool Halozyme Therapeutics Inc , National Institute Of Health , National Institute Of Allergy , Goldman Sachs , Halozyme Therapeutics Inc , Japan Ministry Of Health ,